Clinical Trial Update: Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD [NA]

View source ↗

Summary

Clinical trial update on the safety and efficacy study of the reSept ASD Occluder for treating secundum atrial septal defects. The study status is ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Cardiovascular Disease
• Congenital Heart Defect
• Congenital Heart Disease

Drugs mentioned

• reSept ASD Occluder

Snippet

Sponsor: atHeart Medical | Conditions: Heart Septal Defect, Heart Septal Defects, Atrial | NA | Status: ACTIVE_NOT_RECRUITING